HOME >> MEDICINE >> NEWS
Children's Cancer Fund brings world-class pediatric cancer specialist to Dallas

DALLAS - Dec. 5, 2001 The Childrens Cancer Fund of Dallas, now in its 19th year of supporting laboratory and clinical research, has helped bring one of the worlds most promising young pediatric hematologist/oncologists to UT Southwestern Medical Center at Dallas.

A special Childrens Cancer Fund grant of $525,000, added to previously donated funds, will provide four years of start-up research support for Dr. Scott Cameron. A board-certified pediatric oncologist, Cameron comes to Dallas from the Dana Farber Cancer Institute at Harvard. His research probes the fundamental mechanisms of cell growth, differentiation and death, and the links between natures programmed cell death and cancer.

Cameron is a first-class pediatrician, molecular biologist and cancer specialist, and he will augment UT Southwesterns core of internationally known oncologists and basic scientists already studying the cellular and molecular causes of cancer, said Dr. George Buchanan, professor of pediatrics and director of the universitys pediatric cancer program within the Harold C. Simmons Comprehensive Cancer Center. Buchanan has also been a beneficiary of the Childrens Cancer Funds generosity as holder of the Childrens Cancer Fund Distinguished Chair in Pediatric Oncology and Hematology, established in 1993.

In addition to his position as assistant professor in both pediatrics and molecular biology at UT Southwestern, Cameron will also be an attending physician at Childrens Medical Center of Dallas.

Were very excited about Dr. Cameron coming aboard to enhance cancer research at UT Southwestern and treatment of cancer patients at Childrens Medical Center, said Dr. William S. Edell, president of Childrens Cancer Fund. The organization was formed in 1982 by parents of children being treated for cancer at Childrens Medical Center under the care of UT Southwestern physicians.

In February 2000, the Childrens Cancer Fund provided a $2 million challenge gift to UT
'"/>

Contact: Worth Wren Jr.
Worth.Wren@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
5-Dec-2001


Page: 1 2

Related medicine news :

1. Sleeping Through the Night: Childrens sleep expert advises parents
2. Surgeon General at Childrens Hospital & Research Center at Oakland
3. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
4. Brenner Childrens Hospital named to NIH Pediatric Heart Network
5. Childrens Hospital at Vanderbilt ranked 8th in nation by Child magazine
6. Childrens anxiety prior to surgery linked to behavioral changes
7. Texas Childrens Hospital specialists say proactive approach best defense against flu season
8. Texas Childrens Hospital jumps up in list of Americas Best
9. NIH awards Baylor, Texas Childrens No. 1 spot in pediatric-research funding
10. Researchers at Cincinnati Childrens link a strain of E. coli to diarrhea in children
11. Texas Childrens Hospital implants first MicroMed/DeBakey child ventricular assist device

Post Your Comments:
(Date:7/30/2014)... July 30, 2014 Hospitals continually ... quality of care that their practitioners provide. During ... Andrew Rowe, discussed the importance of establishing effective ... physician performance and quality of care. , ... evaluation, Mr. Rowe elaborated on setting performance expectations, ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent ... this nasty condition which occurs most frequently in people between ... to two and half years if not treated. , Adhesive ... good reason: it can render your shoulder so stiff, it's ... you aren't in too much pain to get dressed in ...
(Date:7/30/2014)... (HealthDay News) --,Although the vast majority of kids with ... wired very differently from children who have trouble processing ... disorders (SPD) can be overly sensitive to sound, sight ... and show a lack of concentration. Complicating matters, ... others. Some have trouble tolerating loud noises, like a ...
(Date:7/30/2014)... India (PRWEB) July 30, 2014 On ... Campaign, and the Indian Institute of Public Health, Gandhinagar ... Microfinance in India, Volume II: The Way Forward .” ... Asia Conference on Policies and Practices to Improve Nutrition ... the "Indian Father of the Green Revolution" and chair ...
(Date:7/30/2014)... 2014 The North America aviation actuator ... 2019. North America is expected to be the fastest ... a CAGR of 5.60%. , The commercial aircraft ... which will assume prominence in the years to come. ... the sector has regained quickly, and the industry has ...
Breaking Medicine News(10 mins):Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 3Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 2Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 3Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 4Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 4
(Date:7/30/2014)... -- Stryker brand ambassadors Fred Funk and Hal ... Tour event near Minneapolis, MN , which begins ... Stryker is the official joint replacement products company of the PGA ... st through Sunday, August 3 rd , fans will be ... destination located in the Pioneer Press Expo tent located near the ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... and SAN DIEGO , July ... ARNA ) announced today that an article based ... of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, ... was recently published in the online issue of Obesity ... The objective of these analyses was to identify whether there ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
Cached News: